PERTILE, Paolo
PERTILE, Paolo
DIPARTIMENTO DI SCIENZE ECONOMICHE
A Bayesian Decision-Theoretic Model of Sequential Experimentation with Delayed Response
2017-01-01 Chick, Stephen; Forster, Martin; Pertile, Paolo
A Large Scale OLG Model for the Analysis of the Redistributive Effects of Policy Reforms
2017-01-01 Bucciol, Alessandro; Cavalli, Laura; Fedotenkov, Igor; Pertile, Paolo; Polin, Veronica; Sartor, Nicola; Sommacal, Alessandro
A reply to "Who would benefit from average value-based pricing?"
2021-01-01 Levaggi, Rosella; Pertile, Paolo
A stepped-wedge randomised controlled trial to assess efficacy and cost-effectiveness of a care-bundle to prevent falls in older hospitalised patients
2024-01-01 Di Gennaro, Gianfranco; Chamitava, Liliya; Pertile, Paolo; Ambrosi, Elisa; Mosci, Daniela; Fila, Alice; Alemayohu, Mulubirhan Assefa; Cazzoletti, Lucia; Tardivo, Stefano; Zanolin, Maria Elisabetta
An extension of the real option approach to the evaluation of health care technologies: the case of positron emission tomography
2009-01-01 Pertile, Paolo
Authors' Reply to Garattini and Freemantle: "Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition"
2020-01-01 Levaggi, Rosella; Pertile, Paolo
Cost-effective clinical trial design: Application of a Bayesian sequential model to the ProFHER pragmatic trial
2021-01-01 Forster, Martin; Brealey, Stephen; Chick, Stephen; Keding, Ada; Corbacho, Belen; Alban, Andres; Pertile, Paolo; Rangan, Amar
Investment in health technologies in a competitive model with real options
2008-01-01 Pertile, Paolo
Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy
2015-01-01 Pertile, Paolo; Poli, Albino; Dominioni, Lorenzo; Rotolo, Nicola; Nardecchia, Elisa; Castiglioni, Massimo; Paolucci, Massimo; Mantovani, William; Imperatori, Andrea
Job Sick Leave: Detecting Opportunistic Behavior
2019-01-01 Biscardo, CARLO ALBERTO; Bucciol, Alessandro; Pertile, Paolo
Late-Stage Pharmaceutical R&D and Pricing Policies under Two-Stage Regulation
2016-01-01 Jobjörnsson, Sebastian; Forster, Martin; Pertile, Paolo; Burman, Carl Fredrik
Optimal Bayesian sequential sampling rules for the economic evaluation of health technologies
2014-01-01 Pertile, Paolo; M., Forster; D., La Torre
Optimal Decision Rules for HTA Under Uncertainty: a Wider, Dynamic Perspective
2013-01-01 Forster, Martin; Pertile, Paolo
Public health interventions: evaluating the economic evaluations
2013-01-01 Martin, Forster; Pertile, Paolo
R&D and market size: who benefits from orphan drug legislation?
2021-01-01 Gamba, Simona; Magazzini, Laura; Pertile, Paolo
Redistribution at the Local Level: The Case of Public Childcare in Italy
2016-01-01 Bucciol, Alessandro; Cavalli, Laura; Pertile, Paolo; Polin, Veronica; Sommacal, Alessandro
Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial
2014-01-01 Tessitore, N; Bedogna, V; Poli, Albino; Lipari, G; Pertile, Paolo; Baggio, Elda; Contro, Alberto; Criscenti, P; Mansueto, Giancarlo; Lupo, Antonio
Static and Dynamic Efficiency of Irreversible Health Care investments under Alternative Payment Rules
2012-01-01 Levaggi, R.; Moretto, M.; Pertile, Paolo
Technology adoption, quality and health care costs: a review of the literature
2006-01-01 Pertile, Paolo
The dynamics of pharmaceutical regulation and R&D investments
2017-01-01 Levaggi, Rosella; Moretto, Michele; Pertile, Paolo